John M. Evans, CEO, Director at Beam Therapeutics, holds 1.16M shares in Beam Therapeutics (Ticker: BEAM), holds ― shares in Verve Therapeutics (Ticker: VERV).
What is the percentage of profitable transactions made by John M. Evans?
The percentage of profitable transactions made by John M. Evans is 60%.
What is the average return per transaction made by John M. Evans?
The average return per transaction made by John M. Evans is 69.20%.
What stocks does John M. Evans hold?
John M. Evans holds: BEAM, VERV stocks.
What was John M. Evans’s latest transaction?
John M. Evans latest transaction was an Uninformative Sell of $581.62K.
What was John M. Evans's most profitable transaction?
John M. Evans’s most profitable transaction was an Informative Buy of BEAM stock on August 17, 2020. The return on the trade was 330.00%.
What is John M. Evans's role in Beam Therapeutics?
John M. Evans's role in Beam Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.